QualityDipStocks / Consumer Discretionary · Specialty distribution
Coupang CPNG
Outside our quality screen, so we don’t track its dips. It’s 55% below its 52-week high.
Outside our quality screen, 5% under its Market Value. No fair value estimate for now: the model’s result is too extreme to stand behind.
- Fair value est.
- n/a
- Market Value
- $15.10price −5%
- Off 52-wk high
- −55%
- Risk vs market
- Above marketbeta 1.36
5 bullish · 5 bearish See why
Key levels
Every level vs today’s $14.37
- 52-wk lowlowest close, 1 year$13.75−4.3%
- PriceFri Oct 30 close$14.37you are here
- Market Valueavg paid since Aug 4$15.10+5.1%
- 52-wk highhighest close, 1 year$32.13+123.6%
Fair value estimate
Estimate unreliable for CPNG: the model gives 88% below the price; trailing free cash flow is small next to the company's value, so a DCF on it says little. We’d rather show nothing than a made-up number.
What the price implies To be worth today’s price, CPNG’s free cash flow would need to grow about 58% a year for five years; our estimate uses 15%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 30 to Oct 30, 252 sessions). Beta = how much CPNG moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings more than the market, and its own price swings are 3.7× the S&P 500’s.
- Beta vs S&P 500
- 1.36
- Volatility
- 47% vs 13% SPY
- Correlation SPY
- 0.37
- Correlation QQQ
- 0.31
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
GrowthDiluted EPS grew 38% to $0.11 in FY2025.
GrowthSales compounded 19% a year from FY2022 to FY2025.
Cash returnsShare count down 3.0% in a year: $1.1B of buybacks over 12 months.
ProfitabilityGross margin widened to 29.4% in FY2025 from 25.4% in FY2023 (SEC filings).
ValuationTrades 4.9% below its Market Value of $15.10, the average price paid since the Aug 4 filing.
Top bearish points 5 of 5
Balance sheetOperating income covers interest only -8.3× over the last 12 months.
ProfitabilityLost $767M over the last 12 months (net income, SEC filings).
Balance sheetDebt rose 98% to $1.6B from FY2023 to FY2025.
Cash returnsFree cash flow fell 87% over the last 12 months vs the 12 months before.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%.
Who’s talking about it
Notable investors, executives, analysts and public figures on Coupang in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 1, 9:09 PM ET.
Compare with peers
Closest in size in Specialty distribution
All fundamentals
FCF yield 0.4% · Sales +10%
Valuation
- P/E
- n/aloss over the last 12 months
- Price / FCF
- 261.1×
- FCF yield
- 0.4%
- EV / EBITDA
- n/aD&A or debt not tagged in SEC data
- Price / sales
- 0.73×
- Price / book
- n/anot reported in its SEC filings
- Market cap
- $25.9Bprice × diluted shares
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $35.5B
- Sales growth, 12 months
- +9.9%vs the 12 months before
- Sales growth, 3 yrs
- +18.8%/yrfrom FY2022
- Diluted EPS, 12 months
- −$0.43
- EPS growth, last FY
- +37.5%
- Net income, 12 months
- −$767M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- 28.4%
- Operating margin
- −1.8%
- Net margin
- −2.2%
- FCF margin
- 0.3%
- Return on equity
- n/anot reported in its SEC filings
- Return on invested capital
- n/aoperating income, debt, equity or cash not tagged
Balance sheet
- Cash & short-term inv.
- n/anot reported in its SEC filings
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/acash or debt not tagged in SEC data
- Debt / equity
- n/adebt or equity not tagged in SEC data
- Interest coverage
- -8.3×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- $99M
- FCF growth, 12 months
- −87%
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- $1.1B4.2% of market cap
- Share count, 1 year
- −3.0%diluted shares vs a year ago
- Stock-based comp
- $524M
Trailing 12 months to Jun 30, 2026. From Coupang’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
Valuation details
MV $15.10 · FCF value $1.37
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Momentum & 52-week range
RSI 49 · 5 days +3.4%
The business
FCF $0.1B · Sales +4%
- Free cash flow, 12 months$0.1B
- Free-cash-flow yield0.4%
- Free-cash-flow margin0%
- Gross margin28%
- Operating margin−2%
- Return on invested capital−9%
- Return on equity−18%
- Sales growth (latest quarter vs year-ago quarter)+4%
- Net debt / EBITDA−14.9×
Next report
Nov 3
- DateTue Nov 3, after the close
- Consensus EPS($0.23)
- Year-ago EPS$0.05
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.
CPNG is outside our quality screen
One text when a published rule fires on one of the 333 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.